Homology Medicines, Inc. (0T6G.L)
USD 3.22
(-5.26%)
USD 3.22
(-5.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.67 Million | -113.66 Million | -109.75 Million | -94.33 Million | -91.35 Million | -42.56 Million |
| Net Income | -53.74 Million | -5 Million | -95.76 Million | -128.69 Million | -103.91 Million | -55.57 Million |
| Depreciation & Amortization | 586 Thousand | 2.59 Million | 9.54 Million | 8.9 Million | 6.31 Million | 1.28 Million |
| Deferred income taxes | -495 Thousand | -19.23 Million | -38.82 Million | -28.59 Million | -24.72 Million | - |
| Stock-based compensation | 1.42 Million | 1.23 Million | 753 Thousand | 13.24 Million | 7.63 Million | 2.62 Million |
| Change in working capital | 50.13 Million | 3.35 Million | -41.8 Million | 11.52 Million | 463 Thousand | 10.56 Million |
| Other non-cash items | -17.08 Million | -108.42 Million | 39.84 Million | 29.28 Million | 22.86 Million | -644 Thousand |
| Investing Cash Flow | -5000.00 | 36.71 Million | -50.78 Million | 204.89 Million | -51.79 Million | -121.78 Million |
| Investments in PPE | -5000.00 | -1.28 Million | -2.39 Million | -3.73 Million | -21.83 Million | -24.93 Million |
| Acquisitions | 554 Thousand | 130 Million | 48.39 Million | -208.62 Million | 29.96 Million | - |
| Investment purchases | -73.24 Million | -157.46 Million | -97.39 Million | -19.99 Million | -286.39 Million | -245.32 Million |
| Sales/Maturities of investments | 174.24 Million | 65.46 Million | 49 Million | 228.62 Million | 256.42 Million | 148.48 Million |
| Other Investing Activities | - | 19 Thousand | -48.39 Million | 208.62 Million | -29.96 Million | -96.84 Million |
| Financing Cash Flow | 406 Thousand | 596 Thousand | 52.16 Million | 53.09 Million | 158.21 Million | 150.99 Million |
| Debt repayment | -300 Thousand | -30 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 184 Thousand | 596 Thousand | 52.16 Million | 53.09 Million | 158.21 Million | 150.99 Million |
| Other Financing Activities | 106 Thousand | 69 Thousand | 20.1 Million | 53.09 Million | 158.21 Million | 150.99 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 2.08 Million | -981 Thousand | -2.48 Million | 2.45 Million | -4.45 Million | 4.38 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 50.13 Million | 4.33 Million | -39.31 Million | 9.06 Million | 4.91 Million | 6.18 Million |
| Cash at beginning of period | 49.54 Million | 108.38 Million | 217.43 Million | 53.77 Million | 38.22 Million | 51.57 Million |
| Cash at end of period | 31.26 Million | 33.98 Million | 108.38 Million | 217.43 Million | 53.77 Million | 38.22 Million |
| Capital Expenditure | -5000.00 | -1.28 Million | -2.39 Million | -3.73 Million | -21.83 Million | -24.93 Million |
| Effect of forex changes on cash | -23.55 Million | 92.9 Million | 141.35 Million | - | - | 1.77 Million |
| Net cash flow / Change in cash | -18.27 Million | -74.39 Million | -109.04 Million | 163.65 Million | 15.55 Million | -13.35 Million |
| Free Cash Flow | -18.68 Million | -114.94 Million | -112.14 Million | -98.06 Million | -113.19 Million | -67.5 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.97 Million | 1.02 Million | -112.96 Million | -27.06 Million | -32.95 Million | -35.04 Million |
| Depreciation & Amortization | 187 Thousand | 152 Thousand | 578 Thousand | 154 Thousand | 136 Thousand | 564 Thousand |
| Deferred income taxes | - | - | -495 Thousand | -5.21 Million | 2.73 Million | -3.77 Million |
| Stock-based compensation | 1.33 Million | 417 Thousand | 1.42 Million | 523 Thousand | 1.4 Million | 2.4 Million |
| Change in working capital | -4.28 Million | -1.5 Million | -7.2 Million | 53.03 Million | 3.13 Million | 3.27 Million |
| Other non-cash items | -2.47 Million | -14.64 Million | 22.42 Million | -37.36 Million | 606 Thousand | 8.91 Million |
| Investing Cash Flow | 9.88 Million | 97 Thousand | 101.32 Million | 31.71 Million | -22.76 Million | 61 Million |
| Investments in PPE | -15 Thousand | - | -228 Thousand | - | 22.76 Million | - |
| Acquisitions | - | - | 554 Thousand | 216 Thousand | 338 Thousand | - |
| Investment purchases | - | - | -73.24 Million | - | -47.95 Million | 1000.00 |
| Sales/Maturities of investments | - | - | 174.24 Million | 31.5 Million | 24.85 Million | 61 Million |
| Other Investing Activities | 9.9 Million | 97 Thousand | - | - | -22.76 Million | 61 Million |
| Financing Cash Flow | -5.52 Million | 99.34 Million | 184 Thousand | 75 Thousand | 18 Thousand | 2000.00 |
| Debt repayment | -5.9 Million | -57.34 Million | -300 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 184 Thousand | 14 Thousand | 18 Thousand | 2000.00 |
| Other Financing Activities | 380 Thousand | 42 Million | 106 Thousand | 75 Thousand | 18 Thousand | 2000.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | 2.08 Million | -4.56 Million | 4.41 Million | -242 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -4.28 Million | -1.5 Million | -9.29 Million | 53.03 Million | -1.27 Million | 3.51 Million |
| Cash at beginning of period | 116.15 Million | 31.26 Million | 33.98 Million | 29.11 Million | 76.79 Million | 39.45 Million |
| Cash at end of period | 98.3 Million | 116.15 Million | 39.26 Million | 31.26 Million | 29.11 Million | 76.79 Million |
| Capital Expenditure | -15 Thousand | - | -228 Thousand | - | 22.76 Million | - |
| Effect of forex changes on cash | - | - | -23.55 Million | 21.1 Million | - | - |
| Net cash flow / Change in cash | -17.84 Million | 84.89 Million | 5.28 Million | 2.15 Million | -47.68 Million | 37.34 Million |
| Free Cash Flow | -22.22 Million | -14.55 Million | -96.45 Million | -10.71 Million | -2.17 Million | -23.66 Million |
688599
ELL
6565
AONNY
MCHOY
APT